1. Home
  2. RVMD vs OKLO Comparison

RVMD vs OKLO Comparison

Compare RVMD & OKLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RVMD
  • OKLO
  • Stock Information
  • Founded
  • RVMD 2014
  • OKLO 2013
  • Country
  • RVMD United States
  • OKLO United States
  • Employees
  • RVMD N/A
  • OKLO N/A
  • Industry
  • RVMD Biotechnology: Biological Products (No Diagnostic Substances)
  • OKLO
  • Sector
  • RVMD Health Care
  • OKLO
  • Exchange
  • RVMD Nasdaq
  • OKLO NYSE
  • Market Cap
  • RVMD 7.5B
  • OKLO 8.2B
  • IPO Year
  • RVMD 2020
  • OKLO N/A
  • Fundamental
  • Price
  • RVMD $37.81
  • OKLO $60.96
  • Analyst Decision
  • RVMD Strong Buy
  • OKLO Strong Buy
  • Analyst Count
  • RVMD 13
  • OKLO 10
  • Target Price
  • RVMD $68.38
  • OKLO $60.00
  • AVG Volume (30 Days)
  • RVMD 3.3M
  • OKLO 17.6M
  • Earning Date
  • RVMD 08-06-2025
  • OKLO 08-12-2025
  • Dividend Yield
  • RVMD N/A
  • OKLO N/A
  • EPS Growth
  • RVMD N/A
  • OKLO N/A
  • EPS
  • RVMD N/A
  • OKLO N/A
  • Revenue
  • RVMD N/A
  • OKLO N/A
  • Revenue This Year
  • RVMD N/A
  • OKLO N/A
  • Revenue Next Year
  • RVMD $226.82
  • OKLO N/A
  • P/E Ratio
  • RVMD N/A
  • OKLO N/A
  • Revenue Growth
  • RVMD N/A
  • OKLO N/A
  • 52 Week Low
  • RVMD $29.17
  • OKLO $5.35
  • 52 Week High
  • RVMD $62.40
  • OKLO $73.55
  • Technical
  • Relative Strength Index (RSI)
  • RVMD 46.33
  • OKLO 60.00
  • Support Level
  • RVMD $36.37
  • OKLO $51.52
  • Resistance Level
  • RVMD $38.97
  • OKLO $57.59
  • Average True Range (ATR)
  • RVMD 1.34
  • OKLO 4.58
  • MACD
  • RVMD 0.07
  • OKLO -0.08
  • Stochastic Oscillator
  • RVMD 37.26
  • OKLO 74.01

About RVMD Revolution Medicines Inc.

Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio and SOS1 and 4EBP1/mTORC1 programs.

About OKLO OKLO INC

Oklo Inc is developing advanced fission power plants to provide clean, reliable, and affordable energy at scale. It is pursuing two complementary tracks to address this demand: providing reliable, commercial-scale energy to customers; and selling used nuclear fuel recycling services to the U.S. market. The Company plans to commercialize its liquid metal fast reactor technology with the Aurora powerhouse product line. The first commercial Aurora powerhouse is designed to produce up to 15 megawatts of electricity (MWe) on both recycled nuclear fuel and fresh fuel.

Share on Social Networks: